The Valens Company Stock Price, News & Analysis
Company Description
The Valens Company (NASDAQ: VLNS) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector. The company has a market capitalization of $61.5M.
VLNS stock has declined 66.2% over the past year.
This page provides a comprehensive overview of VLNS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
The Valens Company (VLNS) stock. Over the past 12 months, the stock has lost 66.2%. At a market capitalization of $61.5M, VLNS is classified as a micro-cap stock with approximately 80.9M shares outstanding.
Latest News
The Valens Company has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, acquisition, management, partnership. View all VLNS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
VLNS Company Profile & Sector Positioning
The Valens Company (VLNS) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.